{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:42:27Z","timestamp":1793817747867,"version":"4.6.1"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.critrevonc.2026.105596","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:50:24Z","timestamp":1789516224000},"page":"105596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["TREM2\u207a tumor-associated macrophages in cancer: Context-dependent biology, biomarkers, and precision immunotherapy"],"prefix":"10.1016","volume":"227","author":[{"given":"Xuejun","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingya","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonggang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9228-6162","authenticated-orcid":false,"given":"Wenxue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105596_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112042","article-title":"Current understanding on TREM-2 molecular biology and physiopathological functions","volume":"134","author":"Bharadwaj","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105596_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109844","article-title":"Targeting TREM2 on tumor-associated macrophages enhances immunotherapy","volume":"37","author":"Binnewies","year":"2021","journal-title":"Cell. Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/gutjnl-2022-327927","article-title":"FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancer","volume":"73","author":"Canel","year":"2023","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib4","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/s42003-025-07512-2","article-title":"Defining gastric cancer ecology: the crucial roles of TREM2(+) macrophages and fibroblasts in tumor microenvironments","volume":"8","author":"Cao","year":"2025","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-023-01830-x","article-title":"Target delivery of a PD-1-TREM2 scFv by CAR-T cells enhances anti-tumor efficacy in colorectal cancer","volume":"22","author":"Chen","year":"2023","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105596_bib7","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.240391","article-title":"Oxidized phospholipid damage signals as modulators of immunity","volume":"15","author":"Choi","year":"2025","journal-title":"Open. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib8","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1038\/s41467-025-62132-y","article-title":"Metabolism archetype cancer cells induce protumor TREM2(+) macrophages via oxLDL-mediated metabolic interplay in hepatocellular carcinoma","volume":"16","author":"Chu","year":"2025","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105596_bib9","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41577-023-00837-1","article-title":"The biology of TREM receptors","volume":"23","author":"Colonna","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105596_bib10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrn.2016.7","article-title":"TREM2 variants: new keys to decipher Alzheimer disease pathogenesis","volume":"17","author":"Colonna","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib11","doi-asserted-by":"crossref","first-page":"5665","DOI":"10.1038\/s41467-024-49885-8","article-title":"Using a pan-cancer atlas to investigate tumour associated macrophages as regulators of immunotherapy response","volume":"15","author":"Coulton","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105596_bib12","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.3389\/fimmu.2026.1749965","article-title":"Targeting MDSCs in cancer: emerging immunotherapeutic and metabolic strategies","volume":"17","author":"Dash","year":"2026","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105596_bib13","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.171776","article-title":"Selective SIK2\/SIK3 inhibition reprograms pro- and antiinflammatory pathways in myeloid cells, improving autoimmune disease outcomes","volume":"11","author":"De Vos","year":"2026","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.7150\/thno.101001","article-title":"A STING agonist prodrug reprograms tumor-associated macrophage to boost colorectal cancer immunotherapy","volume":"15","author":"Deng","year":"2025","journal-title":"Theranostics"},{"issue":"95","key":"10.1016\/j.critrevonc.2026.105596_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adi5374","article-title":"TREM2 deficiency reprograms intestinal macrophages and microbiota to enhance anti-PD-1 tumor immunotherapy","volume":"9","author":"Di Luccia","year":"2024","journal-title":"Sci. Immunol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105596_bib16","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.immuni.2025.12.016","article-title":"Tumor-associated macrophages enhance peripheral nerve tumor infiltration and spinal cord repair","volume":"59","author":"Dolci","year":"2026","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13058-025-02155-x","article-title":"Macrophages in obesity-related breast cancer: mechanistic insights and therapeutic opportunities","volume":"27","author":"Dong","year":"2025","journal-title":"Breast Cancer Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105596_bib18","article-title":"Synthetic cleavage-resistant TREM2 boosts macrophage efferocytosis to treat inflammatory diseases","volume":"7","author":"Dong","year":"2026","journal-title":"Cell. Rep. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-026-68706-8","article-title":"TREM2 expression level is critical for microglial state, metabolic capacity and efficacy of TREM2 agonism","volume":"17","author":"Feiten","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105596_bib20","article-title":"The sTREM2 concentrations in the blood: a marker of neurodegeneration?","volume":"7","author":"Ferri","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.critrevonc.2026.105596_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105630","article-title":"Soluble TREM2: Innocent bystander or active player in neurological diseases?","volume":"165","author":"Filipello","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.critrevonc.2026.105596_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.slasd.2025.100255","article-title":"TREM2 hit discovery using temperature-related intensity change (TRIC) technology: a proof-of-concept high-throughput screening approach","volume":"35","author":"Fuchs","year":"2025","journal-title":"SLAS Discov."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105596_bib23","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/neuonc\/noae019","article-title":"TREM2 function in glioblastoma immune microenvironment: can we distinguish reality from illusion?","volume":"26","author":"Ghosh","year":"2024","journal-title":"Neuro Oncol."},{"issue":"771","key":"10.1016\/j.critrevonc.2026.105596_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adk1168","article-title":"Protumoral lipid droplet-loaded macrophages are enriched in human glioblastoma and can be therapeutically targeted","volume":"16","author":"Governa","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13024-024-00795-9","article-title":"Biophysical mapping of TREM2-ligand interactions reveals shared surfaces for engagement of multiple Alzheimer's disease ligands","volume":"20","author":"Greven","year":"2025","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41392-025-02124-y","article-title":"Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets","volume":"10","author":"Guan","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13046-025-03287-w","article-title":"TREM2 promotes the formation of a tumor-supportive microenvironment in hepatocellular carcinoma","volume":"44","author":"Guo","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105596_bib28","doi-asserted-by":"crossref","DOI":"10.1177\/10732748251316604","article-title":"Macrophage polarisation in the tumour microenvironment: recent research advances and therapeutic potential of different macrophage reprogramming","volume":"32","author":"Guo","year":"2025","journal-title":"Cancer Control."},{"key":"10.1016\/j.critrevonc.2026.105596_bib29","article-title":"The gut-immune axis in primary immune thrombocytopenia (ITP): a paradigm shifts in treatment approaches","volume":"16","author":"Guo","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41392-024-01765-9","article-title":"Harnessing innate immune pathways for therapeutic advancement in cancer","volume":"9","author":"Hu","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41698-025-01152-9","article-title":"TREM2-mediated regulation of myeloid cells in the tumor microenvironment: new insights and therapeutic prospects","volume":"9","author":"Huang","year":"2025","journal-title":"NPJ Precis. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3724\/abbs.2025239","article-title":"An updated overview of lipid-regulated immunobiology in macrophages","volume":"58","author":"Huang","year":"2026","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105596_bib33","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.tips.2024.08.006","article-title":"New insights into SYK targeting in solid tumors","volume":"45","author":"Joshi","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105596_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115332","article-title":"Immunometabolism of tumor-associated macrophages: a therapeutic perspective","volume":"220","author":"Karimova","year":"2025","journal-title":"Eur. J. Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105596_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10060943","article-title":"Exploring the impact of TREM2 in tumor-associated macrophages","volume":"10","author":"Khantakova","year":"2022","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib36","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s40364-025-00757-3","article-title":"Extracellular matrix: unlocking new avenues in cancer treatment","volume":"13","author":"Lee","year":"2025","journal-title":"Biomark. Res."},{"key":"10.1016\/j.critrevonc.2026.105596_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1375729","article-title":"Mechanisms of TREM2 mediated immunosuppression and regulation of cancer progression","volume":"14","author":"Lei","year":"2024","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105596_bib38","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1016\/j.apsb.2025.07.021","article-title":"Understanding the complexity of tumor-associated macrophages: druggable and therapeutic insights","volume":"15","author":"Li","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.critrevonc.2026.105596_bib39","article-title":"Androgen receptor dynamics in prostate cancer: from disease progression to treatment resistance","volume":"15","author":"Li","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105596_bib40","article-title":"Identification of TREM2-positive tumor-associated macrophages in esophageal squamous cell carcinoma: implication for poor prognosis and immunotherapy modulation","volume":"14","author":"Li","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s10565-025-10035-5","article-title":"Neuron-like macrophage differentiation via the APOE-TREM2 axis contributes to chronic pain in nasopharyngeal carcinoma","volume":"41","author":"Li","year":"2025","journal-title":"Cell. Biol. Toxicol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11481-025-10250-1","article-title":"Lipid-metabolically active TREM2(high) microglia\u2011derived macrophages predict poor prognosis and represent an immunotherapeutic target in glioma","volume":"20","author":"Li","year":"2025","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-025-02357-x","article-title":"Lipid metabolism in homeostasis and disease","volume":"11","author":"Li","year":"2026","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-025-02328-2","article-title":"Remodeling the tumor dormancy ecosystem to prevent recurrence and metastasis","volume":"11","author":"Liang","year":"2026","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105596_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70403","article-title":"Decoding MHC loss: molecular mechanisms and implications for immune resistance in cancer","volume":"15","author":"Lin","year":"2025","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib46","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s13046-025-03490-9","article-title":"Targeting tumor-associated macrophages to overcome immune checkpoint inhibitor resistance in hepatocellular carcinoma","volume":"44","author":"Liu","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105596_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2025.12.021","article-title":"Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvironment and control metastatic cancer growth","author":"Mateus-Tique","year":"2026","journal-title":"Cancer Cell."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105596_bib48","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1158\/1541-7786.MCR-24-0791","article-title":"Single-cell and spatial transcriptomics reveal a tumor-associated macrophage subpopulation that mediates prostate cancer progression and metastasis","volume":"23","author":"Mei","year":"2025","journal-title":"Mol. Cancer Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105596_bib49","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.cell.2020.07.013","article-title":"TREM2 Modulation remodels the tumor myeloid landscape enhancing anti-PD-1 immunotherapy","volume":"182","author":"Molgora","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105596_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101739","article-title":"TREM2: a new player in the tumor microenvironment","volume":"67","author":"Molgora","year":"2023","journal-title":"Semin. Immunol."},{"issue":"14","key":"10.1016\/j.critrevonc.2026.105596_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26146838","article-title":"Macrophages at the crossroads of chronic stress and cancer","volume":"26","author":"Momcilovic","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"Pt 3","key":"10.1016\/j.critrevonc.2026.105596_bib52","article-title":"TREM2 activation by first-in-class direct small molecule agonists: DEL screening, optimization, biophysical validation, and functional characterization","volume":"302","author":"Nada","year":"2026","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105596_bib53","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41590-023-01475-4","article-title":"TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer","volume":"24","author":"Park","year":"2023","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105596_bib54","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/s41423-025-01324-4","article-title":"Myeloid cells in chronic liver inflammation","volume":"22","author":"Patseas","year":"2025","journal-title":"Cell. Mol. Immunol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105596_bib55","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/neuonc\/noad257","article-title":"Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma","volume":"26","author":"Peshoff","year":"2024","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-22614-x","article-title":"TREM2 expressing macrophages are not associated with prognostic markers or metabolic syndrome in early stage ER positive breast cancer","volume":"15","author":"Pierro","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-023-00549-7","article-title":"Metabolic regulation of tumor-associated macrophage heterogeneity: insights into the tumor microenvironment and immunotherapeutic opportunities","volume":"12","author":"Qian","year":"2024","journal-title":"Biomark. Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105596_bib58","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41416-024-02715-6","article-title":"Clinical landscape of macrophage-reprogramming cancer immunotherapies","volume":"131","author":"Rannikko","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105596_bib59","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.tips.2024.02.005","article-title":"Leveraging macrophage metabolism for anticancer therapy: opportunities and pitfalls","volume":"45","author":"Saha","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib60","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10238-026-02055-0","article-title":"The role of tumor-associated macrophages in cancer development and their significance as prognostic markers","volume":"26","author":"Salmaninejad","year":"2026","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.critrevonc.2026.105596_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1295684","article-title":"Unraveling the enigma of tumor-associated macrophages: challenges, innovations, and the path to therapeutic breakthroughs","volume":"14","author":"Shao","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105596_bib62","article-title":"Research progress of HIF-1a on immunotherapy outcomes in immune vascular microenvironment","volume":"16","author":"Shi","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105596_bib63","article-title":"TREM2 in MASH: integrating lipid metabolism and immune response","volume":"16","author":"Shi","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105596_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1498993","article-title":"TREM-1 and TREM-2 as therapeutic targets: clinical challenges and perspectives","volume":"15","author":"Sigalov","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70580","article-title":"Stimulator of interferon genes (STING)-activating nanomedicines: translating innate immune modulation into effective therapy for triple-negative breast cancer","volume":"16","author":"Singhai","year":"2026","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib66","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jhep.2023.02.032","article-title":"TREM2(+) macrophages suppress CD8(+) T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma","volume":"79","author":"Tan","year":"2023","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib67","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s43556-025-00396-y","article-title":"Tumor-associated macrophages in cancer: from mechanisms to application","volume":"6","author":"Tang","year":"2025","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.critrevonc.2026.105596_bib68","doi-asserted-by":"crossref","DOI":"10.1002\/1878-0261.70210","article-title":"Cotargeting TREM2 and IL2 pathways triggers multipronged anticancer immunity","author":"Vanmeerbeek","year":"2026","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105596_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2025.104982","article-title":"Revisiting TAM polarization: beyond M1- and M2-type TAM toward clinical precision in macrophage-targeted therapy","volume":"143","author":"Wang","year":"2025","journal-title":"Exp. Mol. Pathol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib70","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1038\/s41467-025-62381-x","article-title":"AR(+)TREM2(+) macrophage induced pathogenic immunosuppression promotes prostate cancer progression","volume":"16","author":"Wang","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib71","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","article-title":"Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance","volume":"8","author":"Wang","year":"2024","journal-title":"NPJ Precis. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib72","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1038\/s41467-023-41470-9","article-title":"Metabolic reprogramming via ACOD1 depletion enhances function of human induced pluripotent stem cell-derived CAR-macrophages in solid tumors","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105596_bib73","article-title":"TREM2(+) macrophages: a key role in disease development","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105596_bib74","article-title":"TREM2-mediated cholesterol efflux in macrophages inhibits anti-tumor immunity via limitation of CD4(+) T and NK Cells","volume":"13","author":"Wang","year":"2026","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib75","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41698-024-00660-4","article-title":"Tumor-associated macrophage clusters linked to immunotherapy in a pan-cancer census","volume":"8","author":"Wei","year":"2024","journal-title":"NPJ Precis. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105596_bib76","article-title":"Polarization of tumor cells and tumor-associated macrophages: molecular mechanisms and therapeutic targets","volume":"6","author":"Wei","year":"2025","journal-title":"MedComm (2020)"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105596_bib77","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70604","article-title":"Comprehensive tumour-immune profiling reveals TREM2(+) tumour-associated macrophages facilitating lymph node metastasis in head and neck squamous cell carcinoma","volume":"16","author":"Wu","year":"2026","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib78","article-title":"Large-scale single-cell analysis and in silico perturbation reveal dynamic evolution of HCC: from initiation to therapeutic targeting","volume":"10","author":"Xia","year":"2026","journal-title":"NPJ Precis. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib79","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","article-title":"Targeting tumor-associated macrophages to synergize tumor immunotherapy","volume":"6","author":"Xiang","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105596_bib80","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00262-024-03748-9","article-title":"The significance of lipid metabolism reprogramming of tumor-associated macrophages in hepatocellular carcinoma","volume":"73","author":"Xie","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-026-69060-5","article-title":"Paclitaxel drives TREM2(+) macrophage expansion underlying its inferior therapeutic efficacy compared to Nab-paclitaxel","volume":"17","author":"Xing","year":"2026","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib82","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","article-title":"Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments","volume":"10","author":"Xu","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib83","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-025-02309-7","article-title":"Protein lipidation in the tumor microenvironment: enzymology, signaling pathways, and therapeutics","volume":"24","author":"Xu","year":"2025","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105596_bib84","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1053\/j.gastro.2025.01.244","article-title":"TREM2 depletion in pancreatic cancer elicits pathogenic inflammation and accelerates tumor progression via enriching IL-1beta(+) Macrophages","volume":"168","author":"Yang","year":"2025","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105596_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189259","article-title":"Targeting lipid metabolism in regulatory T cells for enhancing cancer immunotherapy","volume":"1880","author":"Yang","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105596_bib86","first-page":"725","article-title":"The role of lipid metabolic interactions in reshaping the tumor microenvironment","volume":"58","author":"Yang","year":"2025","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib87","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13046-025-03377-9","article-title":"Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy","volume":"44","author":"Yang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105596_bib88","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010959","article-title":"Myeloid targeting antibodies PY159 and PY314 for platinum-resistant ovarian cancer","volume":"13","author":"Yeku","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib89","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1186\/s12967-025-06799-3","article-title":"TREM2-mediated regulation of microglial activity: a promising target for the treatment of ischemic stroke","volume":"23","author":"Yu","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105596_bib90","article-title":"TREM2 is associated with tumor immunity and implies poor prognosis in glioma","volume":"13","author":"Yu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105596_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.105111","article-title":"Research progress on immunotherapeutics for triple-negative breast cancer from a single-cell perspective","volume":"218","author":"Yuan","year":"2026","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib92","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41419-025-08198-4","article-title":"TREM2 facilitates gastric cancer progression and immune evasion via inhibiting TRIM21-mediated STAT1 degradation in tumor-associated macrophages","volume":"16","author":"Zhang","year":"2025","journal-title":"Cell. Death Dis."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105596_bib93","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ccell.2024.05.001","article-title":"Distinct roles of TREM2 in central nervous system cancers and peripheral cancers","volume":"42","author":"Zhong","year":"2024","journal-title":"Cancer Cell."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105596_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115310","article-title":"Lipid droplet efferocytosis attenuates proinflammatory signaling in macrophages via TREM2- and MS4A7-dependent mechanisms","volume":"44","author":"Zhou","year":"2025","journal-title":"Cell. Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105596_bib95","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13578-024-01292-8","article-title":"New insights into the stromal interaction molecule 2 function and its impact on the immunomodulation of tumor microenvironment","volume":"14","author":"Zhou","year":"2024","journal-title":"Cell. Biosci."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084282600483X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084282600483X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:59:37Z","timestamp":1793087977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104084282600483X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":95,"alternative-id":["S104084282600483X"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105596","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TREM2\u207a tumor-associated macrophages in cancer: Context-dependent biology, biomarkers, and precision immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105596","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105596"}}